Mindset Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
Mindset Pharma Inc. (OTCQB: MSSTF) announced that its CEO, James Lanthier, will participate in the KCSA Psychedelics Investor Conference on October 13-14, 2021. Mr. Lanthier will present live on October 14 at 10:00 a.m. ET. Mindset Pharma focuses on developing next-generation psychedelic medicines for neurological and psychiatric disorders. The conference aims to facilitate direct interaction between publicly-traded companies and investors, enhancing engagement in an innovative format.
- None.
- None.
TORONTO, Oct. 6, 2021 /PRNewswire/ -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that James Lanthier, CEO of Mindset, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.
Mr. Lanthier will present live on Thursday, October 14th at 10:00 a.m. ET. Register to attend here.
For more information about the conference, or to schedule a one-on-one meeting with Mindset's management team, please contact KCSA Strategic Communications at MindSet@kcsa.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
Learn more about VIC and its events at www.virtualinvestorconferences.com.
About Mindset Pharma
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds.
For further information on Mindset, please visit our website at www.mindsetpharma.com.
Forward-Looking Information
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward looking information is frequently characterized bywords such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Additional information regarding risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form for the financial year ended June 30, 2020 dated March 5, 2021. The forward-looking information included in this news release is made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise, except as required by applicable law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mindset-pharma-to-present-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-14th-301393848.html
SOURCE VirtualInvestorConferences.com
FAQ
What is the date of the KCSA Psychedelics Investor Conference?
Who is presenting for Mindset Pharma at the conference?
What time will Mindset Pharma's presentation occur?
Where can I register for the KCSA Psychedelics Investor Conference?
What is the focus of Mindset Pharma's drug development?
